Inhibrx
INBX
INBX
96 hedge funds and large institutions have $139M invested in Inhibrx in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $137M → $139M (+$2.58M)
5.2% less ownership
Funds ownership: 66.65% → 61.45% (-5.2%)
Holders
96
Holding in Top 10
–
Calls
$3.98M
Puts
$1.7M
Top Buyers
| 1 | +$1.17M | |
| 2 | +$1.14M | |
| 3 | +$1.07M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$846K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$815K |
Top Sellers
| 1 | -$4.34M | |
| 2 | -$3.45M | |
| 3 | -$2.94M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$2.37M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.67M |